Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion description "[Estimates of effect for return to heavy drinking suggest it is possible that patients with at least one G allele of A118G polymorphism of OPRM1 might be more likely to respond to naltrexone, but confidence intervals were wide; additional studies are needed to improve confidence in the estimates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion evidence source_evidence_literature NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion SIO_000772 25410894 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion wasDerivedFrom befree-2016 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion wasGeneratedBy ECO_0000203 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.